Giovana Cristo de Oliveira Terças
Research Subjects
Giovana Cristo de Oliveira Terças has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Vitória Rodrigues dos Santos
Medicine Program, Federal University of Acre (UFAC), Rio Branco, Brazil
3 shared publications - Ana Clara Ferreira Asbeque
Universidade Federal do Acre (UFAC), Rio Branco, AC, Brazil; Laboratório Multidisciplinar de Estudos e Escrita Científica em Ciências da Saúde (LaMEECCS), Rio Branco, AC, Brazil
3 shared publications - Elissandra Pereira Machado
Universidade Federal do Acre
3 shared publications - Francisco Naildo Cardoso Leitão
Universidade Federal do Acre
3 shared publications - Ines Nalita D’aVila de Lima Alencar3 shared publications
- Calina da Silva Araújo
Universidade Federal do Acre
2 shared publications
Latest Publications
- Open Access
- 17 December 2025
- Published by Escola Superior de Ciencias da Saude da Santa Casa de Misericordia de Vitoria in Clinics Biopsychosocial
- Vol. 3 (2) , 162-168
Exposição solar e incidência de câncer de pele em áreas rurais: uma revisão sistemática
Introduction: Skin cancer is one of the most prevalent neoplasms in Brazil, especially in rural areas, where cumulative sun exposure tends to be intense. Ultraviolet radiation is the main risk factor, leading to mutations that can develop into melanoma (more lethal) or non-melanoma. Objective: This study addressed, through a systematic review, whether rural residents have a higher prevalence of skin cancer when compared to urban populations. Method: A systematic review without meta-analysis was performed according to the PRISMA 2023 guidelines, registered in PROSPERO, with searches in the PubMed, BVS, and LILACS databases. Studies published between 2020 and 2025 on the diagnosis of skin cancer in rural areas were included. After screening according to inclusion and exclusion criteria, seven studies were included in the final sample. Results: A higher prevalence of skin cancer was found in rural areas, related to advanced stages and late diagnoses. Socioeconomic and demographic factors, such as age, income, and skin type, interfered with predisposition. Rural residents face restricted access to specialized services and travel longer distances for treatment. Occupational sun exposure was a determining factor in incidence. Conclusion: Significant disparities between rural and urban areas are evident, resulting from structural inequalities, lack of information on photoprotection, and occupational risks. Public policies focused on prevention, early detection, and greater access to specialized services can reduce the incidence and mortality of skin cancer among rural populations.
- 17 December 2025
- Published by Escola Superior de Ciencias da Saude da Santa Casa de Misericordia de Vitoria in Clinics Biopsychosocial
- Vol. 3 (2) , 162-168
Open AccessExposição solar e incidência de câncer de pele em áreas rurais: uma revisão sistemática
Introduction: Skin cancer is one of the most prevalent neoplasms in Brazil, especially in rural areas, where cumulative sun exposure tends to be intense. Ultraviolet radiation is the main risk factor, leading to mutations that can develop into melanoma (more lethal) or non-melanoma. Objective: This study addressed, through a systematic review, whether rural residents have a higher prevalence of skin cancer when compared to urban populations. Method: A systematic review without meta-analysis was performed according to the PRISMA 2023 guidelines, registered in PROSPERO, with searches in the PubMed, BVS, and LILACS databases. Studies published between 2020 and 2025 on the diagnosis of skin cancer in rural areas were included. After screening according to inclusion and exclusion criteria, seven studies were included in the final sample. Results: A higher prevalence of skin cancer was found in rural areas, related to advanced stages and late diagnoses. Socioeconomic and demographic factors, such as age, income, and skin type, interfered with predisposition. Rural residents face restricted access to specialized services and travel longer distances for treatment. Occupational sun exposure was a determining factor in incidence. Conclusion: Significant disparities between rural and urban areas are evident, resulting from structural inequalities, lack of information on photoprotection, and occupational risks. Public policies focused on prevention, early detection, and greater access to specialized services can reduce the incidence and mortality of skin cancer among rural populations.
- Open Access
- 17 December 2025
- Published by Escola Superior de Ciencias da Saude da Santa Casa de Misericordia de Vitoria in Clinics Biopsychosocial
- Vol. 3 (2) , 138-144
Mortalidade por melanoma e outras neoplasias malignas da pele por região do Brasil entre 2015 e 2024
Introdução: O melanoma e outras neoplasias malignas da pele representam um desafio crescente para a saúde pública devido à sua alta letalidade e ao aumento da incidência global. No Brasil, o câncer de pele é o mais frequente, e embora o melanoma represente uma pequena parcela dos casos, ele é responsável por uma alta taxa de mortalidade. Objetivo: Analisar a mortalidade por melanoma e outras neoplasias malignas da pele no Brasil entre 2015 e 2024 considerando as diferenças regionais e os principais fatores epidemiológicos, como sexo, idade e raça/cor. Método: Trata-se de um estudo retrospectivo, observacional e ecológico, baseado em dados do Sistema de Informação sobre Mortalidade (SIM), do DATASUS. Foram incluídos óbitos registrados entre 2015 e 2024, classificados sob os códigos CID-10 C43-C44. As variáveis analisadas incluíram região geográfica, sexo, faixa etária e raça/cor. Os dados foram tabulados e analisados utilizando estatísticas descritivas no Microsoft Excel 2019. Resultado: No período analisado, foram registrados 43.956 óbitos por melanoma e outras neoplasias malignas da pele no Brasil. O ano de 2023 apresentou o maior número de óbitos. A mortalidade foi maior no Sudeste, seguido pelo Nordeste e Sul, sendo que a região Sul apresentou a maior taxa de mortalidade proporcional à população. O perfil epidemiológico predominante foi de indivíduos do sexo masculino (57,54%), idosos acima de 80 anos (38,72%) e de raça/cor branca (73,60%). Conclusão: A mortalidade apresentou um aumento significativo no Brasil na última década, com diferenças regionais relevantes.
- 17 December 2025
- Published by Escola Superior de Ciencias da Saude da Santa Casa de Misericordia de Vitoria in Clinics Biopsychosocial
- Vol. 3 (2) , 138-144
Open AccessMortalidade por melanoma e outras neoplasias malignas da pele por região do Brasil entre 2015 e 2024
Introdução: O melanoma e outras neoplasias malignas da pele representam um desafio crescente para a saúde pública devido à sua alta letalidade e ao aumento da incidência global. No Brasil, o câncer de pele é o mais frequente, e embora o melanoma represente uma pequena parcela dos casos, ele é responsável por uma alta taxa de mortalidade. Objetivo: Analisar a mortalidade por melanoma e outras neoplasias malignas da pele no Brasil entre 2015 e 2024 considerando as diferenças regionais e os principais fatores epidemiológicos, como sexo, idade e raça/cor. Método: Trata-se de um estudo retrospectivo, observacional e ecológico, baseado em dados do Sistema de Informação sobre Mortalidade (SIM), do DATASUS. Foram incluídos óbitos registrados entre 2015 e 2024, classificados sob os códigos CID-10 C43-C44. As variáveis analisadas incluíram região geográfica, sexo, faixa etária e raça/cor. Os dados foram tabulados e analisados utilizando estatísticas descritivas no Microsoft Excel 2019. Resultado: No período analisado, foram registrados 43.956 óbitos por melanoma e outras neoplasias malignas da pele no Brasil. O ano de 2023 apresentou o maior número de óbitos. A mortalidade foi maior no Sudeste, seguido pelo Nordeste e Sul, sendo que a região Sul apresentou a maior taxa de mortalidade proporcional à população. O perfil epidemiológico predominante foi de indivíduos do sexo masculino (57,54%), idosos acima de 80 anos (38,72%) e de raça/cor branca (73,60%). Conclusão: A mortalidade apresentou um aumento significativo no Brasil na última década, com diferenças regionais relevantes.
- Open Access
- 17 December 2025
- Published by Escola Superior de Ciencias da Saude da Santa Casa de Misericordia de Vitoria in Clinics Biopsychosocial
- Vol. 3 (2) , 169-178
Mutações nos genes BRCA1 e BRCA2 em câncer de mama e ovário entre mulheres: uma revisão sistemática
Introduction: Mutations in the BRCA1 and BRCA2 genes play a crucial role in the development of breast and ovarian cancer in women, presenting significant implications for public health and prevention strategies. Late detection of these mutations can increase the risk of cancer, and the lack of knowledge about this genetic predisposition hinders the adoption of appropriate preventive measures. Objective: To define the genetic and molecular characteristics associated with BRCA1 and BRCA2 mutations. Method: Systematic review study without meta-analysis, following the gold standard protocol Preferential Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), using robust health sciences literature databases such as Pubmed, Lilacs, Virtual Health Library, and Scientific. Results: The results show that the prevalence of BRCA mutations varies geographically, with 28.3% in Latin America and 33% in Northeast Brazil. More comprehensive genetic testing, such as those conducted in Hungary and Japan, has increased the detection of pathogenic variants. Moreover, research indicates an association between BRCA mutations and a higher incidence of triple-negative breast cancer in young women in Argentina. This geographical and ethnic variability reinforces the need for personalized strategies for diagnosis, prevention, and clinical management. Conclusion: Research indicates that the prevalence of mutations in genes such as BRCA1/2 varies globally, influencing the risk of breast and ovarian cancer, and that precise identification of these mutations is essential for early detection and personalized treatment.
- 17 December 2025
- Published by Escola Superior de Ciencias da Saude da Santa Casa de Misericordia de Vitoria in Clinics Biopsychosocial
- Vol. 3 (2) , 169-178
Open AccessMutações nos genes BRCA1 e BRCA2 em câncer de mama e ovário entre mulheres: uma revisão sistemática
Introduction: Mutations in the BRCA1 and BRCA2 genes play a crucial role in the development of breast and ovarian cancer in women, presenting significant implications for public health and prevention strategies. Late detection of these mutations can increase the risk of cancer, and the lack of knowledge about this genetic predisposition hinders the adoption of appropriate preventive measures. Objective: To define the genetic and molecular characteristics associated with BRCA1 and BRCA2 mutations. Method: Systematic review study without meta-analysis, following the gold standard protocol Preferential Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), using robust health sciences literature databases such as Pubmed, Lilacs, Virtual Health Library, and Scientific. Results: The results show that the prevalence of BRCA mutations varies geographically, with 28.3% in Latin America and 33% in Northeast Brazil. More comprehensive genetic testing, such as those conducted in Hungary and Japan, has increased the detection of pathogenic variants. Moreover, research indicates an association between BRCA mutations and a higher incidence of triple-negative breast cancer in young women in Argentina. This geographical and ethnic variability reinforces the need for personalized strategies for diagnosis, prevention, and clinical management. Conclusion: Research indicates that the prevalence of mutations in genes such as BRCA1/2 varies globally, influencing the risk of breast and ovarian cancer, and that precise identification of these mutations is essential for early detection and personalized treatment.